Hartzel William 4

What Happened William Hartzel, Senior Vice President, Bioservices at Emergent BioSolutions (EBS), was granted 100,111 restricted stock units (RSUs) reported as an acquisition on 2026-04-29. The filing shows an acquisition price of $0 (these were awarded, not purchased). The grant was approved by the Compensation Committee on March 2, 2026, and became effective after stockholder approval of the amended stock plan on April 29, 2026.

Key Details

• Transaction date and terms: 100,111 RSUs granted on 2026-04-29 at $0.00 per unit (award/grant, Form 4 code A).
• Vesting: RSUs vest in three annual installments beginning on the anniversary of the date of approval, subject to continued service (per filing footnotes).
• Each RSU equals the right to receive one share of Emergent common stock, subject to adjustment under the grant agreement.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Filing timeliness: Form 4 filed 2026-05-01 for a 2026-04-29 report—no indication of a late filing in the document.

Context Restricted stock unit grants are a form of compensation that convert to actual shares only if and when they vest; they are common for executives and do not represent an open-market buy or sell. Because vesting is conditioned on continued service, these RSUs may not result in immediate share ownership or a market transaction.